Few techniques that EMS providers utilize are of the high-risk/low-frequency variety. One of these is drug-assisted intubation (DAI). This is a high-risk procedure, because, essentially, a patient’s airway is taken away and EMS providers place themselves in charge of breathing for the patient. Various medications might help to ensure the best care for the patient.
When sedation isn’t enough
Different EMS systems use various medication strategies to accomplish the same objective: safely intubating patients who are losing the ability to maintain their airway. Across the board, the most common medication that’s used for DAI is a sedative, such as etomidate and ketamine. These drugs induce unconsciousness and provide muscle relaxation, which allows providers to attempt intubation. Sedation is necessary because a conscious patient wouldn’t tolerate an advanced airway. Although this approach can be effective in many situations, it doesn’t work for all patients.
Certain patients present with compromised airways, clenched jaws or significant muscle tension that doesn’t resolve with sedation alone. In these situations, paralytic medications might improve intubation success.
Rocuronium and succinylcholine cause temporary skeletal muscle paralysis, which eliminates gag reflexes and reduces resistance during an intubation attempt. This, in turn, creates an ideal intubating condition and might increase first-pass success. However, some EMS systems are hesitant to use paralytics because of the risk of inadequate sedation. If patients receive a paralytic without proper sedation, they might become conscious but unable to move or communicate, which can be traumatic.
Benefits
Studies show that paralytics significantly improve procedural success and overall patient safety compared with sedation-only approaches.
Paralytics’ use is associated with higher first-pass success rates, improved intubation conditions and fewer severe complications.
Some evidence suggests that using paralytics might result in as much as a twofold increase in first-pass success compared with using only a sedative.
By producing total muscle relaxation, paralytics allow for easier tube placement without interference from patient movement as well as help to avoid aspiration risk. Furthermore, paralytics might reduce the inflammatory response that’s associated with acute respiratory distress syndrome, possibly by minimizing excessive intrathoracic pressure changes and preventing alveolar overdistension. These advantages suggest that paralytics can play an important role in optimizing airway management during DAI.
Risks
Despite these benefits, important risks must be considered. The most significant concern is the possibility of an “awake and paralyzed” patient if the patient isn’t adequately sedated. This can lead to severe distress and long-term psychological consequences, such as post-traumatic stress disorder.
Additionally, succinylcholine carries specific risks, such as potassium release that might lead to life-threatening cardiac arrest in patients who have crush injuries, severe burns or certain neuromuscular diseases. Paralytics that are used in DAI also might contribute to increased hypotension, bradycardia or cardiac arrest, particularly in critically ill, trauma and shock patients. These risks highlight the importance of careful patient assessment, medication selection and ongoing monitoring.
Advantages outweigh downside
Overall, evidence suggests that, when used appropriately, the benefits of incorporating paralytics into DAI outweigh the potential downsides. Paralytics can improve intubation conditions, increase first-pass success and reduce complications. However, their safe use depends heavily on education and training. EMS providers must understand proper sedation techniques, paralytic pharmacology, contraindications and post-intubation management. That said, with appropriate training and thoughtful application, the use of paralytics during DAI has the potential to improve airway management and enhance patient outcomes.
